Literature DB >> 11156186

Brazilin augments cellular immunity in multiple low dose streptozotocin (MLD-STZ) induced type I diabetic mice.

K M Yang1, S D Jeon, D S So, C K Moon.   

Abstract

Brazilin, an active principle of Caesalprenia sappan, was examined for its immunopotentiating effects in multiple low dose streptozotocin (MLD-STZ) induced type diabetic mice. Brazilin was intraperitoneally administered for 5 consecutive days to MLD-STZ induced type I diabetic mice. Delayed type hypersensitivity, Con A-induced proliferation of splenocytes and mixed lymphocyte reaction, which had been decreased in diabetic mice, were significantly recovered by the administration of brazilin. Brazilin increased IL-2 production without affecting suppressor cell activity. Con A-induced and IL-2-induced expression of high affinity IL-2 receptors were also enhanced by brazilin. These results indicate that brazilin augments cellular immune responses, which are suppressed in the MLD-STZ induced type I diabetic mice, by increasing IL-2 production and responsiveness of immune cells to IL-2.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11156186     DOI: 10.1007/BF02975252

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  3 in total

1.  Evaluation of Su Fu'ning Lotion's Inhibitory Effects on Bladder Cancer Cells In Vitro and In Vivo by Intravesical Instillation.

Authors:  Liansheng Ren; Xihua Yang; Lili Zhao; Hong Zhang; Jing Wang
Journal:  Integr Cancer Ther       Date:  2015-08-27       Impact factor: 3.279

2.  Brazilin isolated from the heartwood of Caesalpinia sappan L induces endothelium-dependent and -independent relaxation of rat aortic rings.

Authors:  Yu Yan; Yu-cai Chen; Yi-huang Lin; Jing Guo; Zi-ran Niu; Li Li; Shou-bao Wang; Lian-hua Fang; Guan-hua Du
Journal:  Acta Pharmacol Sin       Date:  2015-10-12       Impact factor: 6.150

3.  Multidose streptozotocin induction of diabetes in BALB/c mice induces a dominant oxidative macrophage and a conversion of TH1 to TH2 phenotypes during disease progression.

Authors:  Naxin Sun; Guiwen Yang; Heng Zhao; Huub F J Savelkoul; Liguo An
Journal:  Mediators Inflamm       Date:  2005-08-31       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.